Catalyst Wire Dossier Catalyst Wire Dossier

compound gossyfol acetate

not specified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for compound gossyfol acetate, covering 2023-11-15 to 2023-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial. [Phase 2]

See pricing